Chemoinformaics analysis of 1,3-diaminopropane
| Molecular Weight | 74.127 | nRot | 2 |
| Heavy Atom Molecular Weight | 64.047 | nRig | 0 |
| Exact Molecular Weight | 74.0844 | nRing | 0 |
| Solubility: LogS | 1.111 | nHRing | 0 |
| Solubility: LogP | -1.372 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 2 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 15 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 5 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 3 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 13.8779 |
| nHD | 2 | BPOL | 8.89207 |
| QED | 0.455 |
| Synth | 2.323 |
| Natural Product Likeliness | 0.488 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.009 |
| Pgp-sub | 0.015 |
| HIA | 0.041 |
| CACO-2 | -6.249 |
| MDCK | 0.000832941 |
| BBB | 0.34 |
| PPB | 0.0985659 |
| VDSS | 1.187 |
| FU | 0.903332 |
| CYP1A2-inh | 0.026 |
| CYP1A2-sub | 0.097 |
| CYP2c19-inh | 0.019 |
| CYP2c19-sub | 0.189 |
| CYP2c9-inh | 0.003 |
| CYP2c9-sub | 0.177 |
| CYP2d6-inh | 0.003 |
| CYP2d6-sub | 0.893 |
| CYP3a4-inh | 0.003 |
| CYP3a4-sub | 0.178 |
| CL | 4.965 |
| T12 | 0.524 |
| hERG | 0.037 |
| Ames | 0.084 |
| ROA | 0.635 |
| SkinSen | 0.857 |
| Carcinogencity | 0.129 |
| EI | 0.106 |
| Respiratory | 0.749 |
| NR-Aromatase | 0.008 |
| Antiviral | No |
| Prediction | 0.964868 |